Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Peadiatric And Adult Study Population

Condition:   Lyme Borreliosis Interventions:   Biological: VLA15;   Biological: Placebo Sponsors:   Valneva Austria GmbH;   Pfizer Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials